Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 7:24 PM
Ignite Modification Date:
2025-12-25 @ 5:04 PM
NCT ID:
NCT02855203
Group ID:
EG000
Title:
SABR + Pembrolizumab
Description:
SABR treatment (18Gy-20Gy/1#) followed by 200mg pembrolizumab IV once every 3 weeks for a total of 8 cycles
Stereotactic Ablative Body Radiosurgery (SABR): 18-20Gy in 1 fraction
Pembrolizumab: Pembrolizumab at a dose of 200mg IV, 3-weekly will be delivered for a duration of 6 months, commencing 5 days (+/- 3 days) from the last dose of SABR.
Deaths Number Affected:
7
Deaths Number At Risk:
None
Serious Number Affected:
4
Serious Number At Risk:
30
Other Number Affected:
0
Other Number At Risk:
30
Study:
NCT02855203
Results Section:
NCT02855203
Adverse Events Module:
NCT02855203